Elevated serum neopterin levels in acetaminophen-induced liver injury

Environmental Toxicology and Pharmacology

Volumn 31, Issue 1, 2011, Pages 165-170

  Demirbas, Seref ^a   Cakir, Erdinc ^a   Akgul, Emin Ozgur ^a   Seyrek, Melik ^a   Cayci, Tuncer ^a   Kurt, Yasemin Gulcan ^a   Uysal, Bulent ^a   Aydin, Ibrahim ^a   Kurt, Bulent ^a   Yaman, Halil ^a   Erbil, Mehmet Kemal ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Acetaminophen; Injury; Liver; Neopterin

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; BILIRUBIN GLUCURONIDE; CREATININE; GAMMA GLUTAMYLTRANSFERASE; NEOPTERIN; PARACETAMOL; UREA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; DISEASE MARKER; ENZYME ACTIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; IN VIVO STUDY; LIVER NECROSIS; LIVER TOXICITY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STOMACH TUBE; WISTAR RAT;

ACETAMINOPHEN; ALANINE TRANSAMINASE; ANALGESICS, NON-NARCOTIC; ANIMALS; ASPARTATE AMINOTRANSFERASES; BIOLOGICAL MARKERS; DRUG-INDUCED LIVER INJURY; LIVER; LIVER FUNCTION TESTS; MALE; NECROSIS; NEOPTERIN; RATS; RATS, WISTAR;

ANIMALIA; RATTUS NORVEGICUS;

EID: 78650210192     PISSN: 13826689     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etap.2010.10.003     Document Type: Article

References (41)

1. Alrashed M., Abougoush M., Akgul E.O., Erbil M.K., Boyunaga H., Almarafi A. Detection method of serum and urine neopterin levels by high performance liquid chromatography and clinical applications. Gulhane MJ 2002, 44:273-277. (Article in Turkish).
2. Bessems J.G., Vermeulen N.P. Paracetamol (acetaminophen)-induced toxicity: molecular and biochemical mechanisms, analogues and protective approaches. Crit. Rev. Toxicol. 2001, 31:55-138.
3. Blazka M.E., Elwell M.R., Holladay S.D., Wilson R.E., Luster M.I. Histopathology of acetaminophen-induced liver changes: role of interleukin 1 alpha and tumor necrosis factor alpha. Toxicol. Pathol. 1996, 24:181-189.
4. Blazka M.E., Wilmer J.L., Holladay S.D., Wilson R.E., Luster M.I. Role of proinflammatory cytokines in acetaminophen hepatotoxicity. Toxicol. Appl. Pharmacol. 1995, 133:43-52.
5. Bourdi M., Masubuchi Y., Reilly T.P., Amouzadeh H.R., Martin J.L., George J.W., Shah A.G., Pohl L.R. Protection against acetaminophen-induced liver injury and lethality by interleukin 10: role of inducible nitric oxide synthase. Hepatology 2002, 35:289-298.
6. Dahlin D.C., Miwa G.T., Lu A.Y., Nelson S.D. N-acetyl-p-benzoquinone imine: a cytochrome P-450-mediated oxidation product of acetaminophen. Proc. Natl. Acad. Sci. U.S.A. 1984, 81:1327-1331.
7. Dambach D.M., Watson L.M., Gray K.R., Durham S.K., Laskin D.L. Role of CCR2 in macrophage migration into the liver during acetaminophen-induced hepatotoxicity in the mouse. Hepatology 2002, 35:1093-1103.
8. Denz H., Fuchs D., Huber H., Nachbaur D., Reibnegger G., Thaler J., Werner E.R., Wachter H. Correlation between neopterin, interferon-gamma and haemoglobin in patients with haematological disorders. Eur. J. Haematol. 1990, 44:186-189.
9. Ekong U., Zeng S., Dun H., Feirt N., Guo J., Ippagunta N., Guarrera J.V., Lu Y., Weinberg A., Qu W., Ramasamy R., Schmidt A.M., Emond J.C. Blockade of the receptor for advanced glycation end products attenuates acetaminophen-induced hepatotoxicity in mice. J. Gastroenterol. Hepatol. 2006, 21:682-688.
10. Ferret P.J., Hammoud R., Tulliez M., Tran A., Trebeden H., Jaffray P., Malassagne B., Calmus Y., Weill B., Batteux F. Detoxification of reactive oxygen species by a nonpeptidyl mimic of superoxide dismutase cures acetaminophen-induced acute liver failure in the mouse. Hepatology 2001, 33:1173-1180.
11. Fuchs D., Weiss G., Reibnegger G., Wachter H. The role of neopterin as a monitor of cellular immune activation in transplantation, inflammatory, infectious, and malignant diseases. Crit. Rev. Clin. Lab. Sci. 1992, 29:307-341.
12. Gardner C.R., Heck D.E., Yang C.S., Thomas P.E., Zhang X.J., DeGeorge G.L., Laskin J.D., Laskin D.L. Role of nitric oxide in acetaminophen-induced hepatotoxicity in the rat. Hepatology 1998, 27:748-754.
13. Grypioti A.D., Theocharis S.E., Papadimas G.K., Demopoulos C.A., Papadopoulou-Daifoti Z., Basayiannis A.C., Mykoniatis M.G. Platelet-activating factor (PAF) involvement in acetaminophen-induced liver toxicity and regeneration. Arch. Toxicol. 2005, 79:466-474.
14. Gujral J.S., Bucci T.J., Farhood A., Jaeschke H. Mechanism of cell death during warm hepatic ischemia-reperfusion in rats: apoptosis or necrosis?. Hepatology 2001, 33:397-405.
15. Toxicogenomics: Principles and Applications 2004, Wiley-Liss, Hoboken, NJ. H.K. Hamadeh, C.A. Afshari (Eds.).
16. Huang L., Heinloth A.N., Zeng Z.B., Paules R.S., Bushel P.R. Genes related to apoptosis predict necrosis of the liver as a phenotype observed in rats exposed to a compendium of hepatotoxicants. BMC Genomics 2008, 9:288.
17. Huber C., Batchelor J.R., Fuchs D., Hausen A., Lang A., Niederwieser D., Reibnegger G., Swetly P., Troppmair J., Wachter H. Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma. J. Exp. Med. 1984, 160:310-316.
18. Ishida Y., Kondo T., Ohshima T., Fujiwara H., Iwakura Y., Mukaida N. A pivotal involvement of IFN-gamma in the pathogenesis of acetaminophen-induced acute liver injury. FASEB J. 2002, 16:1227-1236.
19. Ishida Y., Kondo T., Tsuneyama K., Lu P., Takayasu T., Mukaida N. The pathogenic roles of tumor necrosis factor receptor p55 in acetaminophen-induced liver injury in mice. J. Leukoc. Biol. 2004, 75:59-67.
20. James L.P., Kurten R.C., Lamps L.W., McCullough S., Hinson J.A. Tumour necrosis factor receptor 1 and hepatocyte regeneration in acetaminophen toxicity: a kinetic study of proliferating cell nuclear antigen and cytokine expression. Basic Clin. Pharmacol. Toxicol. 2005, 97:8-14.
21. James L.P., Lamps L.W., McCullough S., Hinson J.A. Interleukin 6 and hepatocyte regeneration in acetaminophen toxicity in the mouse. Biochem. Biophys. Res. Commun. 2003, 309:857-863.
22. Kaplowitz N. Drug-induced liver disorders: implications for drug development and regulation. Drug Saf. 2001, 24:483-490.
23. Kaplowitz N. Acetaminophen hepatoxicity: what do we know, what don't we know, and what do we do next?. Hepatology 2004, 40:23-26.
24. Larson A.M. Acetaminophen hepatotoxicity. Clin. Liver Dis. 2007, 11:525-548. vi.
25. Laskin D.L., Gardner C.R. The role of nonparenchymal cells and inflammatory macrophages in hepatotoxicity. Toxicology of the Liver 1998, 297-320. Raven, New York, USA. G.L. Plaa, W.R. Hewitt (Eds.).
26. Laskin D.L., Gardner C.R. Nonparenchymal cells, inflammatory macrophages, and hepatotoxicity. Drug-induced Liver Diseases 2003, 183-212. Marcel Dekker, New York. N. Kaplowitz, L.D. DeLeve (Eds.).
27. Laskin D.L., Gardner C.R., Price V.F., Jollow D.J. Modulation of macrophage functioning abrogates the acute hepatotoxicity of acetaminophen. Hepatology 1995, 21:1045-1050.
28. Lee W.M. Acetaminophen toxicity: changing perceptions on a social/medical issue. Hepatology 2007, 46:966-970.
29. Liu Z.X., Govindarajan S., Kaplowitz N. Innate immune system plays a critical role in determining the progression and severity of acetaminophen hepatotoxicity. Gastroenterology 2004, 127:1760-1774.
30. Liu Z.X., Han D., Gunawan B., Kaplowitz N. Neutrophil depletion protects against murine acetaminophen hepatotoxicity. Hepatology 2006, 43:1220-1230.
31. Masubuchi Y., Bourdi M., Reilly T.P., Graf M.L., George J.W., Pohl L.R. Role of interleukin-6 in hepatic heat shock protein expression and protection against acetaminophen-induced liver disease. Biochem. Biophys. Res. Commun. 2003, 304:207-212.
32. Muller M.M., Curtius H.C., Herold M., Huber C.H. Neopterin in clinical practice. Clin. Chim. Acta 1991, 201:1-16.
33. Murr C., Widner B., Wirleitner B., Fuchs D. Neopterin as a marker for immune system activation. Curr. Drug Metab. 2002, 3:175-187.
34. Nelson S.D. Molecular mechanisms of the hepatotoxicity caused by acetaminophen. Semin. Liver Dis. 1990, 10:267-278.
35. Reibnegger G., Fuchs D., Fuith L.C., Hausen A., Werner E.R., Werner-Felmayer G., Wachter H. Neopterin as a marker for activated cell-mediated immunity: application in malignant disease. Cancer Detect. Prev. 1991, 15:483-490.
36. Ruokonen E., Ilkka L., Niskanen M., Takala J. Procalcitonin and neopterin as indicators of infection in critically ill patients. Acta Anaesthesiol. Scand. 2002, 46:398-404.
37. Sen A., Akin A. Drug use attitude of Turkish armed forces pilots. TAF Prev. Med. Bull. 2004, 3:213-220.
38. Sturgill M.G., Lambert G.H. Xenobiotic-induced hepatotoxicity: mechanisms of liver injury and methods of monitoring hepatic function. Clin. Chem. 1997, 43:1512-1526.
39. Sucher R., Schroecksnadel K., Weiss G., Margreiter R., Fuchs D., Brandacher G. Neopterin, a prognostic marker in human malignancies. Cancer Lett. 2010, 287:13-22.
40. Turgan N., Habif S., Parildar Z., Ozmen D., Mutaf I., Erdener D., Bayindir O. Association between homocysteine and neopterin in healthy subjects measured by a simple HPLC-fluorometric method. Clin. Biochem. 2001, 34:271-275.
41. Yaman H., Cakir E., Ozcan O., Yesilova Z., Ozcan A., Akgul E.O., Erbil M.K., Bagci S., Bilgi C., Dagalp K. Elevated urine neopterin levels in nonalcoholic steatohepatitis. Clin. Biochem. 2005, 38:187-190.